Credit Suisse scoops double role with Bayer

Credit Suisse has won a double role as co-adviser and backer on a friendly, €16.3bn ($19.6bn) bid by German pharmaceutical firm Bayer for local rival Schering. The offer topped a €14.9bn hostile offer from Merck, which was withdrawn this afternoon after the company refused to sweeten it.

Merck said in a statement to the Frankfurt stock exchange that a higher price for Schering could not be justified. Merck was advised by Goldman Sachs, Deutsche Bank and Bear Stearns.

WSJ Logo
Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With TrumpExternal link

Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With Trump